Cargando…

Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network

BACKGROUND: It is well known that information about clinical trials is not easily accessible by the public. In Japan, clinical trial information can be accessed by the general public through online registries; however, many people find these registries difficult to use. To improve current clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogino, Daisuke, Takahashi, Kunihiko, Sato, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234832/
https://www.ncbi.nlm.nih.gov/pubmed/25373358
http://dx.doi.org/10.1186/1745-6215-15-428
_version_ 1782344916978892800
author Ogino, Daisuke
Takahashi, Kunihiko
Sato, Hajime
author_facet Ogino, Daisuke
Takahashi, Kunihiko
Sato, Hajime
author_sort Ogino, Daisuke
collection PubMed
description BACKGROUND: It is well known that information about clinical trials is not easily accessible by the public. In Japan, clinical trial information can be accessed by the general public through online registries; however, many people find these registries difficult to use. To improve current clinical trial registries, we propose that combining them with clinical information phrased in lay terms would be beneficial to other interested professionals such as journalists and clinicians, as well as the general public. Therefore, this study aimed to examine the current pattern of distribution of clinical trial information from the primary World Health Organization (WHO) registries. Based on the results of this assessment, we then aimed to build and evaluate a prototype of the Japan Primary Registries Network (JPRN) portal that would be easily accessible to patients and the public, while still remaining useful for professionals. METHODS: We assessed a total of 14 primary clinical trial registries listed on the WHO International Clinical Trials Registry Platform between January and February 2013. Website content was accessed and checked against a series of items that looked at usability, communication, design and accessibility of the sites. We excluded registries that were not active or were not on the approved WHO registry list at the time of our assessment. We also examined only the English versions of the websites as native-language registries may offer more functionality or different content than the English version of the same website. RESULTS: All registries examined had a function allowing users to search the registry data and that displayed the related information from the search, including the clinical trial registration data. However, few websites were found to be user-friendly, and there was little integration with social media. CONCLUSIONS: We confirmed that there are few websites providing useful clinical trial information to patients and their families. However, information gleaned from some of the more advanced online registries could be used to improve the content and functionality of the JPRN portal.
format Online
Article
Text
id pubmed-4234832
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42348322014-11-19 Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network Ogino, Daisuke Takahashi, Kunihiko Sato, Hajime Trials Research BACKGROUND: It is well known that information about clinical trials is not easily accessible by the public. In Japan, clinical trial information can be accessed by the general public through online registries; however, many people find these registries difficult to use. To improve current clinical trial registries, we propose that combining them with clinical information phrased in lay terms would be beneficial to other interested professionals such as journalists and clinicians, as well as the general public. Therefore, this study aimed to examine the current pattern of distribution of clinical trial information from the primary World Health Organization (WHO) registries. Based on the results of this assessment, we then aimed to build and evaluate a prototype of the Japan Primary Registries Network (JPRN) portal that would be easily accessible to patients and the public, while still remaining useful for professionals. METHODS: We assessed a total of 14 primary clinical trial registries listed on the WHO International Clinical Trials Registry Platform between January and February 2013. Website content was accessed and checked against a series of items that looked at usability, communication, design and accessibility of the sites. We excluded registries that were not active or were not on the approved WHO registry list at the time of our assessment. We also examined only the English versions of the websites as native-language registries may offer more functionality or different content than the English version of the same website. RESULTS: All registries examined had a function allowing users to search the registry data and that displayed the related information from the search, including the clinical trial registration data. However, few websites were found to be user-friendly, and there was little integration with social media. CONCLUSIONS: We confirmed that there are few websites providing useful clinical trial information to patients and their families. However, information gleaned from some of the more advanced online registries could be used to improve the content and functionality of the JPRN portal. BioMed Central 2014-11-05 /pmc/articles/PMC4234832/ /pubmed/25373358 http://dx.doi.org/10.1186/1745-6215-15-428 Text en © Ogino et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ogino, Daisuke
Takahashi, Kunihiko
Sato, Hajime
Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title_full Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title_fullStr Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title_full_unstemmed Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title_short Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
title_sort characteristics of clinical trial websites: information distribution between clinicaltrials.gov and 13 primary registries in the who registry network
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234832/
https://www.ncbi.nlm.nih.gov/pubmed/25373358
http://dx.doi.org/10.1186/1745-6215-15-428
work_keys_str_mv AT oginodaisuke characteristicsofclinicaltrialwebsitesinformationdistributionbetweenclinicaltrialsgovand13primaryregistriesinthewhoregistrynetwork
AT takahashikunihiko characteristicsofclinicaltrialwebsitesinformationdistributionbetweenclinicaltrialsgovand13primaryregistriesinthewhoregistrynetwork
AT satohajime characteristicsofclinicaltrialwebsitesinformationdistributionbetweenclinicaltrialsgovand13primaryregistriesinthewhoregistrynetwork